Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens. It is grouped under the following drug class(es): Leukotriene modifiers. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Azlaire and Onon. Its PubChem CID is 4887.
Pranlukast
| CAS No | 103177-37-3 |
|---|---|
| Molecular Formula | C27H23N5O4 |
| Molecular Weight | 481.5 g/mol |
| Synonyms | N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pranlukast is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
The listed CAS number is 103177-37-3.
The listed molecular formula is C27H23N5O4.
The listed molecular weight is 481.5 g/mol.
N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide.
The source lists Azlaire and Onon.